Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
349 A novel ‘off the shelf’ TCR-NK cell therapy platform for the treatment of solid tumours: development of optimised MAGE-A4 targeting TCR-NK cells for advancement into the clinic
Compose a Response to This Article
Other responses
No responses have been published for this article.